SARS-CoV-2 in tears in patients with COVID-19

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021416

Enrollment

Registered

2020-04-30

Start date

2020-04-29

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

U07.1 H10.2

Interventions

Group 1: The patients are going to be examined for ocular manifestations and for SARS-CoV-2 in their tears.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: stationary COVID-19 patients with positive laryngo-nasal swabs for SARS-CoV-2

Exclusion criteria

Exclusion criteria: Exenteration

Design outcomes

Primary

Measure	Time frame
SARS-CoV-2 RNA detection in tears	—

Secondary

Measure	Time frame
ocular involvement of SARS-CoV-2 infection	—

Countries

Germany

Contacts

Public ContactKristin Hösel

Klinik für Ophthalmologie UKSH Kiel

kristin.hoesel@uksh.de0431/50024201

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026